Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

In a letter seen by MarketWatch, the activist fund blamed the sharp drop in Novavax’s sales on the U.S. vaccine-maker’s ...

A team of Montana researchers is playing a key role in the development of a more effective vaccine against tuberculosis, an ...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips If you have a high tolerance for volatility then the biotech ...

Two Christian health-care workers in Virginia lost their claims that Inova Health Systems’ denial of their requests for ...

A top shareholder of COVID-19 vaccine maker Novavax on Monday said the company has been badly mismanaged and nominated two candidates to serve on Novavax's board.

Amgen AMGN will report first-quarter 2024 results on May 2, before market open. In the last reported quarter, the company ...

Novavax ( NVAX 2.06%) was once a top-performing vaccine stock, soaring more than 2,000% in 2020 on optimism about its ...

I f there is one thing Bluebird Bio (NASDAQ: BLUE) and Novavax (NASDAQ: NVAX) have in common, other than their belonging to ...

Following a meeting of an advisory panel this week, the World Health Organization (WHO) recommended drugmakers to update ...

The new private COVID-19 vaccine, manufactured by Novavax and delivered for the first time in the UK by an independent ...

Believes the two new nominated directors possess the necessary experience to tackle the underperformance of the business which will improve its ...